Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/76970
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Morales-García, José A. | - |
dc.contributor.author | Susín, Cristina | - |
dc.contributor.author | Alonso-Gil, Sandra | - |
dc.contributor.author | Pérez, Daniel I. | - |
dc.contributor.author | Palomo, Valle | - |
dc.contributor.author | Pérez, Concepción | - |
dc.contributor.author | Conde, Santiago | - |
dc.contributor.author | Santos, Ángel | - |
dc.contributor.author | Gil, Carmen | - |
dc.contributor.author | Martínez Gil, Ana | - |
dc.contributor.author | Pérez Castillo, Ana | - |
dc.date.accessioned | 2013-05-28T11:41:17Z | - |
dc.date.available | 2013-05-28T11:41:17Z | - |
dc.date.issued | 2013 | - |
dc.identifier | doi: 10.1021/cn300182g | - |
dc.identifier | issn: 1948-7193 | - |
dc.identifier.citation | ACS Chemical Neuroscience 4(2): 350-360 (2013) | - |
dc.identifier.uri | http://hdl.handle.net/10261/76970 | - |
dc.description.abstract | Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by degeneration of the nigrostriatal dopaminergic pathway. Because the current therapies only lead to temporary, limited improvement and have severe side effects, new approaches to treat PD need to be developed. To discover new targets for potential therapeutic intervention, a chemical genetic approach involving the use of small molecules as pharmacological tools has been implemented. First, a screening of an in-house chemical library on a well-established cellular model of PD was done followed by a detailed pharmacological analysis of the hits. Here, we report the results found for the small heterocyclic derivative called SC001, which after different enzymatic assays was revealed to be a new glycogen synthase kinase-3 (GSK-3) inhibitor with IC50 = 3.38 ± 0.08 μM.To confirm that GSK-3 could be a good target for PD, the evaluation of a set of structurally diverse GSK-3 inhibitors as neuroprotective agents for PD was performed. Results show that inhibitors of GSK-3 have neuroprotective effects in vitro representing a new pharmacological option for the disease-modifying treatment of PD. Furthermore, we show that SC001 is able to cross the blood-brain barrier, protects dopaminergic neurons, and reduces microglia activation in in vivo models of Parkinson disease, being a good candidate for further drug development. © 2012 American Chemical Society. | - |
dc.description.sponsorship | This work was supported by MINECO (Grant SAF2010-16365 to A.P.-C. and Grant SAF2009-13015-C02-01 to A.M.). CIBERNED is funded by the Instituto de Salud Carlos III. | - |
dc.language.iso | eng | - |
dc.publisher | American Chemical Society | - |
dc.rights | closedAccess | - |
dc.title | Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease | - |
dc.type | artículo | - |
dc.identifier.doi | 10.1021/cn300182g | - |
dc.relation.publisherversion | http://dx.doi.org/10.1021/cn300182g | - |
dc.date.updated | 2013-05-28T11:41:17Z | - |
dc.description.version | Peer Reviewed | - |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | - |
dc.contributor.funder | Instituto de Salud Carlos III | - |
dc.contributor.funder | Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas (España) | - |
dc.relation.csic | Sí | - |
dc.identifier.funder | http://dx.doi.org/10.13039/501100003329 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100004587 | es_ES |
dc.identifier.pmid | 23421686 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairetype | artículo | - |
Aparece en las colecciones: | (IQM) Artículos (IIBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
27
checked on 22-abr-2024
SCOPUSTM
Citations
62
checked on 23-abr-2024
WEB OF SCIENCETM
Citations
60
checked on 23-feb-2024
Page view(s)
396
checked on 24-abr-2024
Download(s)
94
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.